L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors |
| |
Authors: | I. Silva H. Cortes E. Escartín C. Rangel L. Florán D. Erlij J. Aceves B. Florán |
| |
Affiliation: | (1) Departamento de Fisiología, Biofísica y Neurociencias del CINVESTAV, México, México;(2) Department of Physiology, Downstate Medical Center, New York, NYU, USA;(3) Laboratory of Alimentary Neurobiology, UNAM, FES Iztacala, Mexico |
| |
Abstract: | The effect of L-DOPA on [(3)H]GABA release in slices of globus pallidus from 6-OHDA-lesioned rats was studied. Release was evoked by high (15 mM) K(+). The lesion reduced dopamine content and dopamine synthesized from L-DOPA. The inhibition of DOPA decarboxylase blocked dopamine synthesis. Endogenous dopamine released by high K(+) inhibited [(3)H]GABA release in normal but not in lesioned slices. L-DOPA inhibited (IC(50) = 0.44 microM) evoked [(3)H]GABA release. The inhibition was via D2-like receptors but not mediated by dopamine. The turning behavior induced by L-DOPA methyl ester (25 mg/kg, i.p.) was not abolished by the DOPA decarboxylase inhibitor 3-hydroxybenzylhydrazine but in this condition it was abolished by sulpiride. Results suggest that L-DOPA acting as D2-like agonist inhibits GABA release in the rat globus pallidus and induces turning behavior in rats with unilateral lesions of the dopamine innervation. L-DOPA could control Parkinson's disease symptoms acting not only as dopamine precursor but also by itself. |
| |
Keywords: | : Dopamine receptors presynaptic D2 receptors L-DOPA effects Parkinson disease AADC NSD-1015 GABA release |
本文献已被 PubMed SpringerLink 等数据库收录! |